Pilot study on the effect of ozone exposure on lung functio
- Conditions
- reduced lung functionlung inflammationRespiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Other inflammatory or immune system disorders
- Registration Number
- ACTRN12621000891820
- Lead Sponsor
- The New Zealand Institute for Plant and Food Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Healthy male and female (50/50) non-pregnant individuals 18-40 years of age with normal lung function at baseline will be selected
If they are unwilling or unable to provide informed written consent or comply with the study procedures.
• If they have a diagnosed health conditions that impair their lung function (asthma, COPD, fibrosis), diabetes or cardiovascular disease.
• If they smoke.
If they work in an environment where they are exposed to high levels of occupational respiratory irritants such as ozone or fine particulate matter (eg welders)
In addition, participants will also be excluded if they have the following health conditions: (i) blood borne diseases (e.g. hepatitis), (ii) clinically diagnosed high/low blood pressure, (iii) recent bacterial or viral illness or (iv) are taking medication that affects the properties of blood (e.g. blood clotting)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method